Steve Young - Arcus Biosciences, Inc

基本信息

浏览量：7

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Abstract PR001: Discovery of Etrumadenant, a First-in-class Dual A2a and A2b Adenosine Receptor Antagonist for Cancer Immunotherapy

Ehesan U. Sharif,Dillon H. Miles,Brandon R. Rosen,Joel Beatty,Jenna L. Jeffrey,Laurent P. P. Debien,Rhiannon Thomas-Tran,Debashis Mandal, Dan Direnzo,Sachie Marubayashi,Kristen Zhang,Ferdie Soriano,Elaine Ginn,Divyank Soni, Pei-Yu Chen,Lixia Jin,Steve W. Young,Matt J. Walters,Manmohan R. Leleti,Jay P. Powers

Molecular Cancer Therapeuticsno. 12_Supplement (2024)

引用0浏览0引用

Discovery of Etrumadenant, a First-in-class Dual A2a and A2b Adenosine Receptor Antagonist for Cancer Immunotherapy

MOLECULAR CANCER THERAPEUTICSno. 12 (2024)

引用0浏览0引用

Characterization of AB598, a Therapeutic Anti-Human CD39 Antibody for the Treatment of Cancer

Amy E. Anderson,Angelo Kaplan,Urvi Vani,Enzo Stagnaro,Kaustubh Parashar,Julie Clor,Nigel P. Walker,Steve W. Young,Matthew J. Walters,Ester Fernandez-Salas,Christine E. Bowman,Lisa Seitz

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract A10: the Dual A2aR/A2bR Antagonist AB928 Reverses Adenosine-Mediated Immune Suppression and Inhibits Tumor Growth in Vivo

Daniel M. DiRenzo,Nell Narasappa,Dana Piovesan,Devika Ashok,Park Adam,Jenna L. Jeffrey,Manmohan R. Leleti,Joanne B.L. Tan,Lisa Seitz,Steve W. Young,Jay P. Powers,Matthew J. Walters

Cancer Immunology Research（2020）

引用0浏览0引用

The Dual A2aR/A2bR Antagonist AB928 Reverses Adenosine-Mediated Immune Suppression and Inhibits Tumor Growth in Vivo

Daniel M. DiRenzo,Nell Narasappa,Dana Piovesan,Devika Ashok,Park Adam,Jenna L. Jeffrey,Manmohan R. Leleti,Joanne B. L. Tan,Lisa Seitz,Steve W. Young,Jay P. Powers,Matthew J. Walters

CANCER IMMUNOLOGY RESEARCHno. 4 (2020): 43-43

引用0浏览0引用

A novel, potent, and selective hypoxia-inducible factor (HIF)-2 alpha antagonist

Kelsey E. Sivick Gauthier,Kenneth V. Lawson,Dana Piovesan,Matthew J. Walters,Ada Chen,Xiaoning Zhao,Cesar Meleza,Nikki Kimura,Tim Park,Steve Young,Anh Tran,Samuel L. Drew,Lixia Jin,Manmohan Leleti,Elaine Ginn,Jay P. Powers

MOLECULAR CANCER THERAPEUTICSno. SUP12 (2019)

引用0浏览0引用

Discovery Of Ab928, A Potent First-In-Class Dual A2a And A2b Receptor Antagonist For Cancer Immunotherapy

Manmohan Leleti,Jenna Jeffrey,Ehesan Sharif,Brandon Rosen,Joel Beatty,Laurent Debien,Rhiannon Thomas-Tran,Debashis Mandal, Wan Lim,Matt Walters,Uli Schindler,Steve Young,Juan Jaen,Jay Powers

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2019)

引用0浏览0引用

Discovery Of Ab680: A Potent And Selective Cd73 Inhibitor For Cancer Immunotherapy

Kenneth Lawson,Jarek Kalisiak,Erick Lindsey,Eric Newcomb,Ehesan Sharif,Dillon Miles,Jenna Jeffrey,Manmohan Reddy Leleti,Ada Chen,Lixia Jin,Joanne Tan,Uli Schindler,Steve Young,Juan Jaen,Jay Powers

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY（2019）

引用0浏览0引用

Abstract C050: A Novel, Potent, and Selective Hypoxia-Inducible Factor (Hif)-2Α Antagonist

Kelsey E Sivick Gauthier,Kenneth V Lawson,Dana Piovesan,Matthew J Walters,Ada Chen,Xiaoning Zhao,Cesar Meleza,Nikki Kimura,Tim Park,Steve Young,Anh Tran,Samuel L Drew,Lixia Jin,Manmohan Leleti,Elaine Ginn,Jay P Powers

Molecular Cancer Therapeuticsno. 12_Supplement (2019)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn